This federal contract award, with ID SPE2DB20D2104|SPE2DB21FS38Z, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,414.72 delivery order contract, with a period of performance ending on April 9, 2021, is for the provision of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical medical commodities.
The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs globally. This IDC, along with a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation, demonstrates Amerisourcebergen's capacity to meet the diverse medical needs of multiple federal agencies through streamlined contracting mechanisms.
Generated 2/27/25, 12:33 PM